Covid-19 Fear and Compliance With Protective Measures of Students

Covid-19 Clinical Trial

Official title:

Covid-19 Fear and Compliance With Protective Measures of Students Continuing Face-to-Face Education in the Covid-19 Pandemic Process

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04849611
• Other study ID #: q9wrjg2p
• Status: Completed
• Start date: November 12, 2020
• Est. completion date: May 1, 2021

Study information

• Verified date: October 2022
• Source: T.C. ORDU ÜNIVERSITESI
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study was carried out to determine the fear of Covid-19 and the compliance with protective measures of students who continue their education face-to-face during the covid-19 pandemic process.

Description:

The study was carried out descriptively. The study population of a province pandemic period junior ongoing training to face in Turkey. Sample constituted reached 188 students with snowball sampling method. The data of the study were collected using the "Questionnaire Form" prepared by the researchers and the "Covid-19 Fear Scale". Data collection tools were applied to the participants electronically via Google Forms.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 188
• Est. completion date: May 1, 2021
• Est. primary completion date: March 30, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 12 Years to 18 Years

Eligibility

Inclusion Criteria:

Students who volunteered to participate in the study, had their parents' consent, had a web-based smart device, and continued face-to-face education were included. Exclusion Criteria: -

Related Conditions & MeSH terms

• Covid-19

Locations

Country	Name	City	State
Turkey	Ordu University	Ordu	Ordu Province

Sponsors (1)

Lead Sponsor	Collaborator
T.C. ORDU ÜNIVERSITESI

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2022;20(3):1537-1545. doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27. — View Citation

Bakioglu F, Korkmaz O, Ercan H. Fear of COVID-19 and Positivity: Mediating Role of Intolerance of Uncertainty, Depression, Anxiety, and Stress. Int J Ment Health Addict. 2021;19(6):2369-2382. doi: 10.1007/s11469-020-00331-y. Epub 2020 May 28. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Information Form	The form consists of two parts. In the first part, there are 14 questions that determine the socio-demographic characteristics of the students (age, gender, class, family type, mother education, father education, monthly income level, knowledge about Covid-19, information source, catching Covid-19, family's catching Covid-19, worrying about the family in terms of the illness, thinking that they can be protected from Covid-19 and being knowledgeable about the methods of protection from Covid-19). In the second part, the practices of students on protection methods from Covid-19 were prepared within the framework of mask (14 questions), hand washing (8 questions) and social distance (17 questions) measures. No scoring will be made in this section. Students' compliance with protective measures will be evaluated as "yes" "no" "sometimes".	November-March
Primary	Covid-19 Fear	Covid-19 Fear Scale: The scale developed by Ahorsu et al. (2020) was adapted to Turkish by Bakioglu, Korkmaz and Ercan (2020). The scale, consisting of seven questions, is a 5-point Likert (1: Strongly disagree, 5: Strongly agree) type. The scale consists of one dimension. The scores that can be obtained from the scale range from 7 to 35. The total score obtained from all items of the scale reflects the level of Covid-19 fear experienced by the individual. A high score means experiencing a high level of fear.	November-March